Secondary listings on SGX set to grow in 2026, but regulatory frictions loom
Well-known companies with such listings here include DFI Retail Group, IHH Healthcare, Nio and Prudential
[SINGAPORE] With three recent sizeable secondary listings bringing the total on the Singapore Exchange (SGX) to 29, industry players expect more entrants this year, especially with the streamlining of some regulatory processes.
“We do see some secondary listings in the pipeline and the trend should continue in 2026,” said Foo Siang Sheng, Singapore head of investment banking at CGS International Securities Singapore.
Robson Lee, partner at Kennedys Law and a director of Legal Solutions LLC, said foreign issuers may show growing interest in secondary listings as a way to “test” the upcoming SGX-Nasdaq dual-listing bridge in the near term, before deciding whether to fully tap the framework once it is implemented.
TRENDING NOW
CSE Global independent director quits after clashes with chairman Eugene Lai over board refresh
Room for more offices, homes and green spaces to make Orchard Road more vibrant
‘I felt like dying’: Thai Singha beer scion speaks up after disclosure of alleged sexual abuse
MAS revises takeover and merger code to enhance competition and disclosures